Medicus Pharma Ltd. (MDCXW)
NASDAQ: MDCXW
· Real-Time Price · USD
2.69
0.19 (7.60%)
At close: May 23, 2025, 3:50 PM
2.41
-10.41%
After-hours: May 23, 2025, 04:00 PM EDT
Company Description
Medicus Pharma Ltd. is a clinical-stage biotech company focused on accelerating the development of novel therapeutic assets.
Their lead subsidiary, SkinJect Inc., is developing a non-invasive treatment for basal cell carcinoma using a dissolvable microneedle patch to deliver chemotherapeutic agents directly to tumor cells.
Medicus Pharma Ltd.
| Country | CA |
| IPO Date | Nov 14, 2024 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | n/a |
| CEO | Dr. Raza Bokhari M.B.A., M.D., MBA |
Contact Details
Address: One First Canadian Place, Suite 3400 Toronto, ON M5X 1A Toronto, CA | |
| Website | https://medicuspharma.com/ |
Stock Details
| Ticker Symbol | MDCXW |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001997296 |
| CUSIP Number | n/a |
| ISIN Number | CA58471K1113 |
| Employer ID | 98-1778211 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Raza Bokhari M.B.A., M.D., MBA | Chief Executive Officer & Executive Chairman |
| James P. Quinlan CPA | Chief Financial Officer |
| Anna Baran-Djokovic J.D. | Senior Vice President of Investor Relations |
| Carolyn Bonner | President |
| Dr. Edward J. Brennan Jr., F.A.C.S., FACS, M.D. | Chief Scientific Officer and Head of R&D Program |
| Dr. Faisal Mehmud M.D. | Chief Medical Officer |
| Maryann Adesso | Chief of Staff |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 21, 2025 | 3/A | [Amend] Filing |
| May 21, 2025 | 4 | Filing |
| May 15, 2025 | SCHEDULE 13G | Filing |
| May 13, 2025 | 253G2 | Filing |
| May 13, 2025 | 424B3 | Filing |
| May 12, 2025 | 10-Q | Quarterly Report |
| May 05, 2025 | 424B3 | Filing |
| May 05, 2025 | 253G2 | Filing |
| May 05, 2025 | 8-K | Current Report |
| Apr 30, 2025 | 10-K/A | [Amend] Annual Report |